{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T21:37:52Z","timestamp":1648935472672},"reference-count":12,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":12739,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[1980,11]]},"abstract":"<jats:title>SUMMARY:<\/jats:title><jats:p>The main purpose of this study was to examine the effects of intraventricular injections of glutamate and aspartate on the walking gait of rendered ataxic by the administration of 3-acetyl pyridine. Both amino acids significantly improved the walking gait of these animals. The effects of other substances known to have a stimulatory influence on locomotor activity in rats were also investigated. Amphetamine, apomorphine and thyrotropin releasing hormone (TRH) had no effect on the ataxic gait of 3-AP treated animals. Substance P significantly improved the gait of ataxic animals, but to a lesser extent than that seen with glutamate and aspartate.<\/jats:p>","DOI":"10.1017\/s0317167100023052","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T11:33:48Z","timestamp":1469705628000},"page":"451-454","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Glutamate and Aspartate on Ataxic Gait Induced by 3-Acetyl Pyridine in Rats"],"prefix":"10.1017","volume":"7","author":[{"given":"G.","family":"De Michele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.B.","family":"Jolicoeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.B.","family":"Rondeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.F.","family":"Butterworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Barbeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"S0317167100023052_ref009","first-page":"793","article-title":"Effects of 3-acetyl pyridine on the levels of several amino acids in different CNS regions of the rat","volume":"3","author":"Mcbride","year":"1978","journal-title":"Ncurochcm. Res"},{"key":"S0317167100023052_ref008","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100119663"},{"key":"S0317167100023052_ref007","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100119742"},{"key":"S0317167100023052_ref006","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/30.4.466"},{"key":"S0317167100023052_ref005","first-page":"189","article-title":"Pathologic effects of antimetabolites","volume":"31","author":"Hicks","year":"1955","journal-title":"Amer. J. Path"},{"key":"S0317167100023052_ref004","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(75)90598-3"},{"key":"S0317167100023052_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(74)90627-1"},{"key":"S0317167100023052_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(74)90628-3"},{"key":"S0317167100023052_ref010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1977.tb10439.x"},{"key":"S0317167100023052_ref011","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1980.tb09947.x"},{"key":"S0317167100023052_ref001","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1017\/S0317167100024914","article-title":"Cerebellar ataxia produced by 3-acetyl pyridine in rat","volume":"5","author":"Butterworth","year":"1978","journal-title":"Can. J. Neurol. Sci"},{"key":"S0317167100023052_ref012","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.31.4.330"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100023052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T21:11:03Z","timestamp":1568236263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100023052\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,11]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1980,11]]}},"alternative-id":["S0317167100023052"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100023052","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,11]]}}}